Prostate cancer: 7. Radiation therapy for localized disease

CMAJ. Canadian Medical Association Journal

Volumn 159, Issue 11, 1998, Pages 1381-1388

  Warde, Padraig ^a,b   Catton, Charles ^a   Gospodarowicz, Mary K ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b Princess Margaret Hospital   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; CORTISONE; GONADORELIN; IRIDIUM; PALLADIUM; PAPAVERINE; PHENAZOPYRIDINE; SALAZOSULFAPYRIDINE; SILDENAFIL; SPASMOLYTIC AGENT; STEROID;

ARTICLE; BEAM THERAPY; BLADDER DISEASE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CLINICAL TRIAL; ERECTILE DYSFUNCTION; GASTROINTESTINAL DISEASE; HORMONAL THERAPY; HUMAN; INTERSTITIAL RADIATION; MALE; OUTCOMES RESEARCH; PROSTATE CANCER; RADIATION DOSE; RADIATION INJURY; TREATMENT PLANNING;

EID: 0032441581     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Moore M, O'Sullivan B, Tannock I. How expert physicians would wish to be treated if they had genitourinary cancer. J Clin Oncol 1988;6:1736-45.
2. Grimm P, Blasko J, Ragde H, Sylvester J, Clarke C. Does brachytherapy have a role in the treatment of prostate cancer? Hematol Oncol Clin North Am 1996;10:653-90.
3. Bagshaw M, Cox R, Hancock S. Control of prostate cancer with radiotherapy: long-term results. J Urol 1994;152:1781-5.
4. International Union against Cancer. TNM classification of malignant tumours. New York: Wiley-Liss, Inc; 1997.
5. Duncan W, Warde P, Catton C, Munro A, Lakier R, Gadalla T, et al. Carcinoma of the prostate: results of radical radiotherapy (1970-1985). Int J Radiat Oncol Biol Phys 1993;26:203-10.
6. Perez C, Hanks G, Leibel S, Zietman A, Fuks Z, Lee W. Localized carcinoma of the prostate (stages T1b, T1c, T2 and T3): review of management with external beam radiation therapy. Cancer 1993;72:3156-73.
7. Shipley W, Prout G, Coachman N, McManus P, Healey E. Radiation therapy for localized prostate cancer: experience at the Massachusetts General Hospital (1973-1981). J Natl Cancer Inst Monogr 1988;7:67-73.
8. Zagars G, von Eschenbach A, Johnson D, Oswald M. The role of radiation therapy in stages A2 and B adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys 1988;14:701-9.
9. American Society for Therapeutic Radiology and Oncology Consensus Panel. Consensus statement: guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 1997;37:1035-41.
10. Zietman A, Coen J, Dallow K, Shipley W. The treatment of prostate cancer by conventional radiation therapy: an analysis of long-term outcome. Int J Radiat Oncol Biol Phys 1995;32:287-92.
11. Zietman A, Prince E, Nakfoor B, Shipley W. Neoadjuvant androgen suppression with radiation in the management of locally advanced adenocarcinoma of the prostate: experimental and clinical results. Urology 1997;49:74-83.
12. Bolla M, Gonzalez D, Warde P, Dubois J, Mirimanoff R, Storme G, et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 1997;337:295-300.
13. Pilepich M, Winter K, Roach M, Russell A, Sause W, Rubin P, et al. Phase III Radiation Therapy Oncology Group (RTOG) trial 86-10 of androgen deprivation before and during radiotherapy in locally advanced carcinoma of the prostate [abstract A1185]. Proc ASCO 1998;17:308a.
14. Laverdiere J, Gomez JL, Cusan L, Suburu ER, Diamond P, Lemay M, et al. Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer. Int J Radiat Oncol Biol Phys 1997;37:247-52.
15. Pollack A, Zagars G. External beam radiotherapy dose response of prostate cancer. Int J Radiat Oncol Biol Phys 1997;39:1011-8.
16. Hanks G, Hanlon A, Pinover W, Al-Saleem T, Schultheiss T. Radiation therapy as treatment for stage Tic prostate cancers. World J Urol 1997;15:369-72.
17. Teshima T, Hanks G, Hanlon A, Peter R, Schultheiss T. Rectal bleeding after conformal 3D treatment of prostate cancer: rime to occurrence, response to treatment and duration of morbidity. Int J Radiat Oncol Biol Phys 1997;39:77-83.
18. Zelefsky MJ, Leibel SA, Gaudin PB, Kutcher GJ, Fleshner NE, Venkatramen ES, et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 1998; 41:491-500.
19. D'Amico AV, Whittington R, Kaplan I, Beard C, Jiroutek M, Malkowicz SB, et al. Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of 4-20 ng/ml. Int J Radiat Oncol Biol Phys 1997;37:1053-8.
20. Reinstein L, Wang X, Burman C, Chen Z, Mohan R, Kutcher G, et al. A feasibility study of automated inverse treatment planning for cancer of the prostate. Int J Radiat Oncol Biol Phys 1998;40:207-14.
21. Porter A, Blasko J, Grimm P, Reddy S, Ragde H. Brachytherapy for prostate cancer. CA Cancer J Clin 1995;45:165-78.
22. Ragde H, Blasko J, Grimm P, Kenny G, Sylvester J, Hoak D, et al. Brachytherapy for clinically localized prostate cancer: results at 7- and 8-year follow-up. Semin Surg Oncol 1997;13:438-43.
23. D'Amico A, Coleman C. Role of interstitial radiotherapy in the management of clinically organ-confined prostate cancer: the jury is still out. J Clin Oncol 1996;14:304-15.
24. Wallner K, Roy J, Harrison L. Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma. J Clin Oncol 1996;14:449-53.
25. Stock R, Stone N, Iannuzzi C. Sexual potency following interactive ultrasound-guided brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys 1996;35:267-72.
26. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998;280:969-74.
27. Bagshaw M, Cox R, Ray G. Status of radiation treatment of prostatic cancer at Stanford University. J Natl Cancer Inst Monogr 1988;7:47-51.
28. Beard C, Propert K, Reiker P, Clark J, Kaplan I, Kantoff P, et al. Complications after treatment with external beam irradiation in early-stage prostate cancer patients: a prospective multiinstitutional outcomes study. J Clin Oncol 1997;15:223-30.
29. Perez C, Brady L, editors. Principles and practice of radiation oncology. 2nd ed. Philadelphia: JB Lippincott; 1992. p. 51-5.
30. Shipley W, Zietman A, Hanks G, Coen J, Caplan R, Won M, et al. Treatment related sequelae following external beam radiation for prostate cancer: a review with an update in patients with stages T1 and T2 tumor. J Urol 1994;152:1799-805.
31. Perez C, Lee H, Anastasios G, Lockett M. Technical factors affecting morbidity in definitive irradiation for localized carcinoma of the prostate. Int J Radiat Oncol Biol Phys 1994;28:811-8.
32. Benk V, Adams J, Shipley W, Urie M, McManus P, Efird J, et al. Late rectal bleeding following combined x-ray and proton high dose irradiation for stages T3-T4 prostate cancer. Int J Radiat Oncol Biol Phys 1993;26:551-7.
33. Middleton R, Thompson I, Austenfeld M, Cooner W, Correa R, Gibbons R, et al. Prostate Cancer Clinical Guidelines Panel summary report on the management of clinically localized prostate cancer. J Urol 1995;154:2144-8.